Prep-free colonoscopy system well tolerated

Check-Cap reported final results from its U.S. pilot study of its C-Scan System, a preparation-free colorectal cancer detection system.

Researchers evaluated the C-Scan System on a pilot basis. Forty patients ingested a C-Scan capsule, and then underwent a fecal immunochemical test and a comparative colonoscopy. Twenty-eight of the patients were evaluable.

All 40 patients completed the procedure and a questionnaire afterward. All 40 patients said their satisfaction levels were higher after the C-Scan than the colonoscopy.

Researchers found the 28 evaluable patients had similar CRC polyp detection profiles to the company's previous post-CE approval study.

Check-Cap will now begin the investigational device exemption process. The company expects to launch a U.S. pivotal study in late 2020. The C-Scan already received regulatory approvals in the European Union and Israel.

More articles on surgery centers:
Montecito Medical buys MOB, ASC in Virginia: 4 details
Arkansas hospital breaks ground on ASC — 4 insights
204 new ASCs opened or announced in 2019

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers